$4450
$3560
The pediatric cardiology market size is projected to reach US$ 10,389.77 million by 2031 from US$ 6,634.00 million in 2024 and is expected to register a CAGR of 6.6% during 2024-2031. The integration of AI and machine learning with pediatric cardiology is likely to bring new trends in the pediatric cardiology market in the coming years.
Pediatric Cardiology Market Analysis
The factors driving the pediatric cardiology market include the increasing incidence of congenital heart disease in pediatrics and the growing shift toward minimally invasive procedures. Additionally, increasing awareness about congenital heart disease and supportive government policies and grants for the development of pediatric cardiology devices are expected to contribute to the market growth. Moreover, the strategic initiatives by companies are expected to create ample opportunities in the coming years.
Pediatric Cardiology Market Overview
The market growth is ascribed to the increasing incidence of congenital heart disease in pediatrics and growing shift toward minimally invasive procedures. North America is expected to dominate the pediatric cardiology market, and Asia Pacific is expected to register a significant growth rate owing to increasing healthcare access and rising pediatric cardiac diseases. Countries such as India, China, and Japan are estimated to emerge as highly rewarding markets due to the presence of organizations focusing on developing pediatric care. In addition, the pediatric cardiology market in Asia Pacific is expected to continue expanding, driven by advancements in medical technology and favorable government initiatives that fuel the adoption of pediatric cardiology solutions. China accounts for the major market share, and India registers a significant growth rate in the region. The increasing prevalence of CHDs and advancements in medical technology drive the demand for pediatric cardiology solutions in India. According to Children’s HeartLink’s data, approximately 240,000 children are born with CHD each year in India, of which an estimated 144,000 infants have an urgent need to undergo heart procedures. 90% of children who have CHD lack the necessary access to heart care. Children's HeartLink has partnered with several Indian hospitals, aiming to develop 12 centers of excellence by 2030 by focusing on building clinical and organizational skills to ensure high-quality care for children with heart conditions.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pediatric Cardiology Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pediatric Cardiology Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pediatric Cardiology Market Drivers and Opportunities
Growing Shift Toward Minimally Invasive Procedures Favors Market Growth
Traditionally, open-heart surgery was the primary approach for addressing congenital heart defects and other cardiac conditions in children. However, the introduction of minimally invasive techniques has revolutionized treatment paradigms, offering several advantages, including less postoperative pain, reduced recovery times, and shorter hospital stays. The adoption of minimally invasive techniques remains essential in cardiac surgical procedures due to increased patient satisfaction, and it also provides a competitive edge to healthcare institutions in an ever-changing medical field. The ability to perform complex procedures through small incisions not only enhances recovery but also minimizes the risks associated with major surgeries, making these options particularly appealing for young patients. Minimally invasive procedures such as catheter-based interventions for atrial septal defects and patent ductus arteriosus closure have become increasingly common in pediatrics globally. Institutions such as Boston Children's Hospital and Texas Children's Hospital are leading the way in employing these techniques, utilizing advanced imaging technologies such as 3D echocardiography and fluoroscopy to guide precise interventions. Advancements in robotic-assisted surgery are propelling the demand for minimally invasive procedures. Robotic systems allow for greater precision and control during procedures, facilitating operations such as valve repair and transcatheter aortic valve replacement in pediatric patients. Robotically assisted cardiac surgery is a feasible and safe approach for pediatric patients as they can easily perform surgeries that have small incisions. As training programs and clinical protocols for these techniques expand, more institutions are adopting minimally invasive approaches. Thus, the growing shift toward minimally invasive techniques, especially robotic systems for pediatric cardiology procedures, drives the global pediatric cardiology market.
Strategic Initiatives by Companies Create Ample Opportunities for Market Growth
Companies operating in the global pediatric cardiology market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them boost their sales, geographic reach, and capacities to cater to a wide customer base. A few strategic initiatives taken by key players operating in the global pediatric cardiology market are mentioned below:
- In August 2024, the Alliance for Pediatric Device Innovation (APDI) partnered with Additional Ventures to solicit proposals and offer grant funding for the development of pediatric devices specifically evaluated and labeled for children with heart conditions. Additional Ventures is a nonprofit foundation focused on accelerating research progress and improving clinical care for individuals born with single-ventricle heart defects. APDI and Additional Ventures are soliciting proposals for pediatric heart devices with a US$ 300,000 grant fund.
- In May 2024, Stanford Medicine researchers developed an implantable ventricular assist device that allows children suffering from heart failure to live relatively normal lives while they get a transplant. The pump, a new type of ventricular assist device, or VAD, is surgically attached to the heart to enhance its blood-pumping action in such children, which helps delay heart failure and provide time to locate a donor's heart.
- In January 2024, Occlutech received the United States Food and Drug Administration (FDA) for Occlutech Pistol Pusher and Occlutech ASD Occluder for the treatment of atrial septal defects (ASD). With this approval, Occlutech will immediately commence commercialization in an exclusive partnership with distributor B. Braun Interventional Systems Inc..
Therefore, strategic initiatives by various companies focusing on the development of pediatric cardiology devices are likely to offer growth opportunities to the global pediatric cardiology market in the coming years.
Pediatric Cardiology Market Report Segmentation Analysis
Key segments that contributed to the derivation of the pediatric cardiology market analysis are product type, disease indication, surgical procedure, and end user.
- Based on product type, the pediatric cardiology market is segmented into transcatheter heart valves, occlusion devices, catheters, stents, introducer sheaths, and others. The transcatheter heart valves segment held the largest share of the market in 2024, and the occlusion devices segment is expected to register the highest CAGR in the market during 20242024-2031.
- By disease indication, the pediatric cardiology market is segmented into congenital heart disease, acquired heart disease, arrhythmias, cardiomyopathies, and others. The congenital heart disease segment held the largest share of the market in 2024 and is expected to register the highest CAGR in the market during 20242024-2031.
- By surgical procedures, the pediatric cardiology market is segmented into interventional procedures, heart rhythm management procedures, and others. The interventional procedures segment held the largest share of the market in 2024 and is expected to register the highest CAGR in the market during 20242024-2031.
- In terms of end user, the pediatric cardiology market is segmented into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2024 and is anticipated to register the highest CAGR during 20242024-2031.
Pediatric Cardiology Market Share Analysis by Geography
The geographical scope of the pediatric cardiology market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America held a significant share of the market in 2024. The increasing incidence of congenital heart disease, increasing strategic initiatives by companies, and government initiatives to improve cardiovascular disease prevention and treatment are among the key factors accelerating the pediatric cardiology market. Additionally, the rising prevalence of congenital anomalies and growing healthcare infrastructure are propelling the expansion of the market in the region. The US pediatric cardiology market’s growth trajectory is influenced by surging inclination toward minimally invasive procedures. As per the American Academy of Pediatrics, about 3–4% of infants in the US are born with congenital abnormalities, highlighting the need for specialized pediatric cardiologists and effective treatment techniques. Technologies such as fetal echocardiography, advanced imaging techniques, and minimally invasive surgeries have improved diagnosis and treatment procedures.
Additionally, increasing strategic initiatives such as product approvals, product launches, and collaborations are expected to create ample opportunities in the market in the coming years. In May 2024, Stanford Medicine researchers developed an implantable ventricular assistance device (VAD) that is surgically attached to the heart of children suffering from heart failure in order to enhance circulation and prevent the risk of heart failure while awaiting a donor’s heart for transplant.
Pediatric Cardiology Market Report Scope
Pediatric Cardiology Market News and Recent Developments
The pediatric cardiology market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the pediatric cardiology market are listed below:
- Renata Medical received the Food and Drug Administration's approval for this new Minima stent device that is specifically tailored for neonates, infants, and young children. It is also designed to be re-expanded over the course of their growth period. This approval marks a groundbreaking advancement in the care of young children facing congenital heart defects. (Source: Renata Medical, Company Website, August 2024)
- Occlutech received the US Food and Drug Administration’s approval for Occlutech ASD Occluder and Occlutech Pistol Pusher for the treatment of atrial septal defects (ASD). With this approval, Occlutech will immediately begin commercialization in an exclusive partnership with distributor B. Braun Interventional Systems Inc. (B. Braun Interventional Systems). (Source: Occlutech US LLC, Company Website, January 2024)
- Medtronic relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). Harmony TPV was designed to treat patients with RVOT anomalies who develop severe pulmonary valve regurgitation, a condition where blood leaks back into the right lower chamber of the heart after being pumped into the lungs. The Harmony TPV provides these patients with a minimally invasive alternative. (Source: Medtronic PLC, Company Website, February 2024)
- Pediatric Cardiology Market Report Coverage and Deliverables
- The “Pediatric Cardiology Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Pediatric cardiology market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Pediatric cardiology market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Pediatric cardiology market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the pediatric cardiology market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the pediatric cardiology market in 2024.
The increasing incidence of congenital heart disease in pediatrics and a growing shift toward minimally invasive procedures are the most influential factors responsible for the market growth.
Abbott Laboratories, Medtronic Plc, Edwards Lifesciences Corp, Terumo Corp, W L Gore and Associates Inc, NuMED, Cordis Corp, Occlutech US LLC, Biotronik SE & Co KG, and RENATA MEDICAL are among the key players operating in the pediatric cardiology market.
The estimated value of the pediatric cardiology market can reach US$ 10,389.77 million by 2031.
The global pediatric cardiology market is estimated to register a CAGR of 6.6% during the forecast period.
The List of Companies - Pediatric Cardiology Market
- Abbott Laboratories
- Medtronic Plc
- Edwards Lifesciences Corp
- Terumo Corp
- W L Gore and Associates Inc
- NuMED
- Cordis Corp
- Occlutech US LLC
- Biotronik SE & Co KG
- RENATA MEDICAL
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Pediatric Cardiology Market
Mar 2025
Pediatric Cardiology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Transcatheter Heart Valves, Occlusion Devices, Catheters, Stents, Introducer Sheaths, and Others), Disease Indication (Congenital Heart Disease, Acquired Heart Disease, Arrhythmias, Cardiomyopathies, and Others), Surgical Procedure (Interventional Procedures, Heart Rhythm Management Procedures, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2025
Pharmaceutical Membrane Filters Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Microfiltration, Ultrafiltration, Reverse Osmosis and Nanofiltration), Design (Hollow Fiber, Spiral Wound, Tubular System and Plate and Frame), Material (Polyethersulfone (PES), Polysulfone (PS), Cellulose-Based Membranes, Polytetrafluoroethylene (PTFE), Polyvinyl Chloride (PVC), Polyacrylonitrile (PAN) and Others), End User (Pharmaceutical and Biotech Industries and CROs and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
Mar 2025
ECG Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG and Stress ECG), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2025
Surgical Laser Fiber Units Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (CO2 Laser, Diode Laser, Erbium Laser, Nd:YAG Laser, Holmium Laser, Alexandrite Laser, and Others), Material (Silica-Based Fibers, Quartz Fibers, Polymer-Based Fibers, Multimode Fibers, and Others), Power (Low-Power Lasers, Medium-Power Lasers, and High-Power Lasers), Application (Urology, Dermatology, Gynecology, Cardiology, Neurology, Ophthalmology, Respiratory, Dentistry and Others), Wavelength (9,301 nm and above, 2,941–9,300 nm, and 1,441–2,940 nm, 821–1,440 nm, 710–820 nm, and below 710 nm), End User (Hospitals, Specialty Clinics, Physician Office, and Others), and Geography
Mar 2025
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography
Mar 2025
Medical Cables Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Disposable Medical Cables, Reusable Medical Cables, and Custom Medical Cables), Applications [Diagnostics (Ultrasound Cables, Endoscopy Cables, Patient Interface Cables, and Others), Motorized Equipment, Patient Monitoring (ECG Cables, SpO2 Cables, NiBP Cables, EEG Cables, and Others), Surgical and Life Support (Fiber Optics, Modular Local Area Network, and Others), and Others], End User (Hospital and Clinics, Diagnostic Laboratories and Imaging Centers, Ambulatory Surgical Centers, and Others), and Geography
Mar 2025
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Mar 2025
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography